发明名称 |
COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS |
摘要 |
The present invention relates to combination therapies for treating Alzheimer's disease or an amyloidosis-associated pathological condition comprising co-administering a therapeutically effective amount of a first compound, and a therapeutically effective amount of a second compound. In certain embodiments, the first compound or the second compound inhibits AB peptide polymerization; is an anti-inflammatory; improves cognitive function, mood, or social behavior; is associated with Tau or alpha-synuclein; or regulates amyloid peptide washout. |
申请公布号 |
WO2014066318(A1) |
申请公布日期 |
2014.05.01 |
申请号 |
WO2013US66069 |
申请日期 |
2013.10.22 |
申请人 |
THE GENERAL HOSPITAL CORPORATION;ELMALEH, DAVID, R. |
发明人 |
ELMALEH, DAVID, R. |
分类号 |
A61K31/4162;A61K31/70;A61P25/00;A61P25/28;C07D471/00;C07D498/00;C07H5/02;C07H17/00 |
主分类号 |
A61K31/4162 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|